FDA Inspection 885403 — Medicap Laboratories

Medicap Laboratories — FEI 3006370451

The FDA completed an inspection of Medicap Laboratories on May 24, 2014 in Etobicoke. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Etobicoke (Canada)